Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (2355)	7/29/1999 2:41:00 AM
From: Dan Spillane	Respond to of 2539

I don't think so! Who are "industry sources"? Competitors, or (once again) Greenpeace? (From your article) Industry sources in Europe say Monsanto might improve its fortunes by taking several steps: * Softening its opposition to segregating genetically modified crops in the United States. * Ceasing for now its drive to commercialize bovine growth hormone in Europe. * Backing away conclusively from the so-called "Terminator," a genetic technology still on the drawing boards that would render the seeds of modified crops sterile.